Back to top
more

Dentsply Sirona (XRAY)

(Delayed Data from NSDQ)

$26.39 USD

26.39
3,241,068

+0.03 (0.11%)

Updated Jul 22, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (160 out of 250)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Illumina (ILMN) Preliminary Q1 Revenues Rebound, '21 View Up

Illumina's (ILMN) revenue improvement in the first quarter is likely to have been boosted by on-going business recovery.

Here's Why You Should Hold on to Bruker (BRKR) Stock for Now

Investors continue to be optimistic about Bruker (BRKR) on its slew of product launches and potential in the BSI Nano Group.

Quest Diagnostics (DGX) Divests Minority Share of Q2 Solutions

Quest Diagnostics' (DGX) divestment of Q2 solutions to IQVIA will allow IQVIA to lead Q2 Solutions on the next stage of its journey in central lab services as a global leader.

Henry Schein's (HSIC) New Deal Boosts Ambulatory Surgery Market

Henry Schein's (HSIC) recent majority ownership in Stradis Healthcare will advance the former's commitment to offer specialty solutions to customers.

Integra's (IART) Neurosurgery Rebounds Despite Supply Issues

Integra LifeSciences (IART) is confident of achieving long-term goals of 5% to 7% revenue growth organically,

Illumina's (ILMN) Grail Merger in Trouble as FTC Files Suit

According to FTC, the Illumina (ILMN) and Grail merger will diminish the scope of innovation in the U.S. market for MCED tests.

Surging Earnings Estimates Signal Upside for Dentsply (XRAY) Stock

Dentsply (XRAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Why You Should Add DENTSPLY SIRONA (XRAY) to Your Portfolio

Investor confidence is high in the DENTSPLY SIRONA (XRAY) stock, thanks to solid prospects.

DENTSPLY SIRONA's (XRAY) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in DENTSPLY SIRONA (XRAY).

Here's Why You Should Retain Cooper Companies (COO) Now

Investors remain optimistic about Cooper Companies (COO) backed by strong CSI and CVI product portfolios and its continued leadership in the specialty lenses market.

Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

Zacks Industry Outlook Highlights: McKesson Corp, West Pharmaceutical Services, Cardinal Health, Align Technology and Dentsply Sirona

Trina Mukherjee headshot

3 Stocks to Capitalize on Promising Dental Supplies Industry

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

DENTSPLY SIRONA (XRAY) at a 52-Week High: What's Driving It?

DENTSPLY SIRONA (XRAY) is optimistic about growth in CAD/CAM business arm along with its recent product launch and strategic buyouts.

DENTSPLY SIRONA (XRAY) Q4 Earnings & Revenues Beat Estimates

DENTSPLY SIRONA (XRAY) witnesses consumable revenue growth in the fourth quarter.

Why Earnings Season Could Be Great for DENTSPLY (XRAY)

DENTSPLY (XRAY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Thermo Fisher (TMO) Rides on Pharma & Biotech Amid Pandemic

Customers in Thermo Fisher's (TMO) industrial and applied end markets get affected by business disruptions due to the pandemic.

What's in Store for Fulgent Genetics (FLGT) in Q4 Earnings?

We expect strong demand for Fulgent Genetics' (FLGT) end-to-end tests for COVID-19 to have continued through the fourth quarter.

Integra (IART) Arms Grow Sequentially Despite Supply Issues

Integra LifeSciences (IART) is confident of achieving long-term goals of 5% to 7% revenue growth organically.

DENTSPLY SIRONA (XRAY) to Post Q4 Earnings: What's in Store?

DENTSPLY SIRONA's (XRAY) fourth-quarter results are likely to reflect weak segmental performance.

Bruker (BRKR) Rides on Product Launches Amid COVID-19 Woes

Within Bruker's (BRKR) Nano Group Semiconductor metrology revenues have been steady with order rates improving as semi metrology equipment markets are witnessing a rebound.

Dentsply International (XRAY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Dentsply (XRAY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Urmimala Biswas headshot

4 Medical Products Stocks Set to Beat This Earnings Season

Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.

LabCorp's (LH) New Antigen Test to Spot Active COVID-19 Virus

LabCorp's (LH) new antigen test is the newest development to detect COVID-19 infection at every single stage, from diagnostic testing to vaccination trails.

Medtronic (MDT) Progresses in SNM With Updated InterStim Label

Medtronic (MDT) expects this updated labeling with wider procedural options and shorter wait time to improve patient access to MRI exams and add more flexibility for MRI providers.

Owens & Minor (OMI) to Report Q4 Earnings: What's in Store?

We expect the strength in demand for Owens & Minor's (OMI) PPEs to have continued through the fourth quarter.